The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
Self-citationLowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Self-citationDupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421
Self-citationNograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
Self-citationDavidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711
Self-citationChiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Self-citationAmelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I., Khatcherian, A., Bluth, M. J., Lowes, M. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071094 · Cited by 676
Self-citationPossible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & Tokura, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 671
Noda, S., Suárez-Fariñas, M., Ungar, B., Kim, S. J., de Guzman Strong, C., Xu, H., Peng, X., Estrada, Y. D., Nakajima, S., Honda, T., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.015 · Cited by 657
Self-citationThe immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Brunner, P. M., Guttman-Yassky, E., & Leung, D. Y. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.011 · Cited by 642
Self-citationThe immunogenetics of Psoriasis: A comprehensive review
Harden, J. L., Krueger, J. G., & Bowcock, A. M. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.008 · Cited by 616
Self-citationCellular and molecular immunologic mechanisms in patients with atopic dermatitis
Werfel, T., Allam, J.-P., Biedermann, T., Eyerich, K., Gilles, S., Guttman-Yassky, E., Hoetzenecker, W., Knol, E., Simon, H.-U., Wollenberg, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.010 · Cited by 594
Self-citationSugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 539
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J.-P., Menter, A., Philipp, S., Sofen, H., Tyring, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514
Self-citationSuárez-Fariñas, M., Dhingra, N., Gittler, J., Shemer, A., Cardinale, I., de Guzman Strong, C., Krueger, J. G., & Guttman-Yassky, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.046 · Cited by 483
Self-citationDeciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approaches
Leung, D. Y. M., & Guttman-Yassky, E. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.008 · Cited by 474
Self-citationHamilton, J. D., Suárez-Fariñas, M., Dhingra, N., Cardinale, I., Li, X., Kostic, A., Ming, J. E., Radin, A. R., Krueger, J. G., Graham, N., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.013 · Cited by 469
Self-citationZaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442
Self-citationEarly-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.013 · Cited by 428 · cited 2×
“by Th22 T-cells, as this disease feature was more responsive to an IL-22 antibody in AD as compared to use of the same antibody in psoriasis patients; still the STAT3 activation response in keratinocytes would be similar in AD and psoriasis, although different ‘IL-20 family’ cytokines may be drivers [5,6,11,14,15].”
BackgroundResultSelf-citationContrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts
Guttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.053 · Cited by 384
Self-citationMelanocyte antigen triggers autoimmunity in human psoriasis
Arakawa, A., Siewert, K., Stöhr, J., Besgen, P., Kim, S.-M., Rühl, G., Nickel, J., Vollmer, S., Thomas, P., Krebs, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151093 · Cited by 361
Sofen, H., Smith, S., Matheson, R. T., Leonardi, C. L., Calderon, C., Brodmerkel, C., Li, K., Campbell, K., Marciniak, S. J., Wasfi, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.025 · Cited by 320
Self-citationResident and “Inflammatory” Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319
Self-citationGuttman-Yassky, E., Nograles, K. E., & Krueger, J. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.054 · Cited by 314
Self-citationSuárez-Fariñas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., & Krueger, J. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.184 · Cited by 305
Self-citationPapp, K., Thaçi, D., Reich, K., Riedl, E., Langley, R. G., Krueger, J. G., Gottlieb, A. B., Nakagawa, H., Bowman, E. P., Mehta, A., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13932 · Cited by 276
Self-citationKrueger, J. G., Ferris, L. K., Menter, A., Wagner, F., White, A., Visvanathan, S., Lalovic, B., Aslanyan, S., Wang, E. E. L., Hall, D., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.01.018 · Cited by 256
Self-citationGuttman-Yassky, E., Lowes, M. A., Fuentes-Duculan, J., Whynot, J., Novitskaya, I., Cardinale, I., Haider, A., Khatcherian, A., Carucci, J. A., Bergman, R., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.006 · Cited by 247
Self-citationSystemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment
Guttman‐Yassky, E., Krueger, J. G., & Lebwohl, M. G. (2018) · Experimental Dermatology · doi:10.1111/exd.13336 · Cited by 225
Self-citationEfficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis
Khattri, S., Brunner, P. M., Garcet, S., Finney, R., Cohen, S. R., Oliva, M., Dutt, R., Fuentes‐Duculan, J., Zheng, X., Li, X., et al. (2017) · Experimental Dermatology · doi:10.1111/exd.13112 · Cited by 214
Self-citationAn Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease
Ungar, B., Garcet, S., Gonzalez, J., Dhingra, N., Correa da Rosa, J., Shemer, A., Krueger, J. G., Suarez-Farinas, M., & Guttman-Yassky, E. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.09.037 · Cited by 213
Self-citationThe translational revolution and use of biologics in patients with inflammatory skin diseases
Noda, S., Krueger, J. G., & Guttman-Yassky, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.015 · Cited by 198
Self-citationIL-17 Induces an Expanded Range of Downstream Genes in Reconstituted Human Epidermis Model
Chiricozzi, A., Nograles, K. E., Johnson-Huang, L. M., Fuentes-Duculan, J., Cardinale, I., Bonifacio, K. M., Gulati, N., Mitsui, H., Guttman-Yassky, E., Suárez-Fariñas, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090284 · Cited by 180
Self-citationKhattri, S., Shemer, A., Rozenblit, M., Dhingra, N., Czarnowicki, T., Finney, R., Gilleaudeau, P., Sullivan-Whalen, M., Zheng, X., Xu, H., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.003 · Cited by 180
Self-citationCzarnowicki, T., Krueger, J. G., & Guttman-Yassky, E. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.03.006 · Cited by 179
Self-citationHighly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis
Kim, J., & Krueger, J. G. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-103905 · Cited by 174
Self-citationChronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunity
Okada, S., Puel, A., Casanova, J., & Kobayashi, M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.71 · Cited by 167
Ewald, D. A., Malajian, D., Krueger, J. G., Workman, C. T., Wang, T., Tian, S., Litman, T., Guttman-Yassky, E., & Suárez-Fariñas, M. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0133-x · Cited by 166
Self-citationIL-17 targeted therapies for psoriasis
Chiricozzi, A., & Krueger, J. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.806483 · Cited by 160
Self-citationFujita, H., Shemer, A., Suárez‐Fariñas, M., Johnson-Huang, L. M., Tintle, S. J., Cardinale, I. R., Fuentes‐Duculan, J., Novitskaya, I., Carucci, J. A., Krueger, J. G., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.016 · Cited by 148
Self-citationChoy, D. F., Hsu, D. K., Seshasayee, D., Fung, M. A., Modrusan, Z. D., Martin, F., Liu, F., & Arron, J. R. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.044 · Cited by 132
Mansouri, Y., & Guttman‐Yassky, E. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4050858 · Cited by 130
Self-citationFuentes‐Duculan, J., Bonifacio, K. M., Hawkes, J. E., Kunjravia, N., Cueto, I., Li, X., Gonzalez, J., Garcet, S., & Krueger, J. G. (2017) · Experimental Dermatology · doi:10.1111/exd.13378 · Cited by 129
Self-citationNew pathogenic and therapeutic paradigms in atopic dermatitis
Malajian, D., & Guttman‐Yassky, E. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.023 · Cited by 119
Self-citationChiricozzi, A., Suárez‐Fariñas, M., Fuentes‐Duculan, J., Cueto, I., Li, K., Tian, S., Brodmerkel, C. M., & Krueger, J. G. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14034 · Cited by 108
Self-citationZaba, L. C., Fuentes‐Duculan, J., Eungdamrong, N. J., Johnson-Huang, L. M., Nograles, K. E., White, T. R., Pierson, K. C., Lentini, T., Suárez‐Fariñas, M., Lowes, M. A., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.018 · Cited by 106
Self-citationDrug Evaluation Review: Dupilumab in Atopic Dermatitis
Hamilton, J. D., Ungar, B., & Guttman‐Yassky, E. (2015) · Immunotherapy · doi:10.2217/imt.15.69 · Cited by 95
Self-citationGuttman‐Yassky, E., & Krueger, J. G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08135.x · Cited by 72
Self-citationShlyankevich, J., Mehta, N. N., Krueger, J. G., Strober, B. E., Gudjonsson, J. E., Qureshi, A. A., Tebbey, P. W., & Kimball, A. B. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.08.008 · Cited by 71
Self-citationBieber, T. R. M., Akdiş, C. A., Lauener, R. P., Traidl‐Hoffmann, C., Schmid‐Grendelmeier, P., Schäppi, G., Allam, J., Apfelbacher, C., Augustin, M., Beck, L. A., et al. (2016) · Allergy · doi:10.1111/all.12857 · Cited by 59
Self-citationDhingra, N., Suárez‐Fariñas, M., Fuentes‐Duculan, J., Gittler, J. K., Shemer, A., Raz, A., Fischetti, V. A., Krueger, J. G., & Guttman‐Yassky, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.043 · Cited by 54
Self-citationThe ‘omics’ revolution: redefining the understanding and treatment of allergic skin diseases
Oliva, M., Renert‐Yuval, Y., & Guttman‐Yassky, E. (2016) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000306 · Cited by 49
Self-citationEsaki, H., Czarnowicki, T., Gonzalez, J., Oliva, M., Talasila, S., Haugh, I. M., Rodriguez, G., Becker, L., Krueger, J. G., Guttman‐Yassky, E., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.052 · Cited by 44
Self-citationAssessing the current treatment of atopic dermatitis: Unmet needs
Leung, D. Y. M., & Guttman‐Yassky, E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.010 · Cited by 31
Self-citation
Cited by
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Developmental cell programs are co-opted in inflammatory skin disease
Reynolds, G., Vegh, P., Fletcher, J., Poyner, E. F. M., Stephenson, E., Goh, I., Botting, R. A., Huang, N., Olabi, B., Dubois, A., et al. (2021) · Science · doi:10.1126/science.aba6500 · Cited by 529
Tsoi, L. C., Rodriguez, E., Degenhardt, F., Baurecht, H., Wehkamp, U., Volks, N., Szymczak, S., Swindell, W. R., Sarkar, M. K., Raja, K., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.018 · Cited by 469
Balić, A., Vlašić, D., Žužul, K., Marinović, B., & Bukvić Mokos, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030741 · Cited by 400
Eosinophils from Physiology to Disease: A Comprehensive Review
Ramirez, G. A., Yacoub, M.-R., Ripa, M., Mannina, D., Cariddi, A., Saporiti, N., Ciceri, F., Castagna, A., Colombo, G., & Dagna, L. (2018) · BioMed Research International · doi:10.1155/2018/9095275 · Cited by 316
Metadata
- Authors
- Guttman-Yassky, E., & Krueger, J. G.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 48
- Pages
- 68-73
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W2752670171
- Cited by
- 412
- References
- 56
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.